152 related articles for article (PubMed ID: 32601382)
21. Anti-histone H3.3K36M Antibody is a Highly Sensitive and Specific Immunohistochemistry Marker for the Diagnosis of Chondroblastoma. A Validation Based on Study 136 Cases Comprising Chondroblastoma and its Mimics from Single a Centre in India.
Hui M; Uppin SG; Narayanan R; Kancherla NR; Kamble A; B RR; Patnala C
Int J Surg Pathol; 2023 Jun; 31(4):375-386. PubMed ID: 35786027
[No Abstract] [Full Text] [Related]
22. Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center.
Rekhi B; Dave V; Butle A; Dutt A
Ann Diagn Pathol; 2023 Oct; 66():152174. PubMed ID: 37356274
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of β-catenin expression in the differential diagnosis of osteosarcoma, osteoblastoma, and chondroblastoma.
Erdogan KE; Pacheco M; Gambarotti M; Magagnoli G; Sbaraglia M; Frisoni T; Righi A; Dei Tos AP
Virchows Arch; 2021 Sep; 479(3):529-535. PubMed ID: 33511430
[TBL] [Abstract][Full Text] [Related]
24. H3F3A G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
[TBL] [Abstract][Full Text] [Related]
25. Histones and their practical application in bone tumors: Do I always need them?
Reith JD
Hum Pathol; 2024 May; 147():92-100. PubMed ID: 38307341
[TBL] [Abstract][Full Text] [Related]
26. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.
Behjati S; Tarpey PS; Presneau N; Scheipl S; Pillay N; Van Loo P; Wedge DC; Cooke SL; Gundem G; Davies H; Nik-Zainal S; Martin S; McLaren S; Goodie V; Robinson B; Butler A; Teague JW; Halai D; Khatri B; Myklebost O; Baumhoer D; Jundt G; Hamoudi R; Tirabosco R; Amary MF; Futreal PA; Stratton MR; Campbell PJ; Flanagan AM
Nat Genet; 2013 Dec; 45(12):1479-82. PubMed ID: 24162739
[TBL] [Abstract][Full Text] [Related]
27. H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
[TBL] [Abstract][Full Text] [Related]
28. Distal Femoral Non-Epiphyseal Cortical Chondroblastoma Confirmed with
Gu H; Sun L; Cui J; Yu L; Wang J
Fetal Pediatr Pathol; 2023 Apr; 42(2):320-326. PubMed ID: 36048092
[No Abstract] [Full Text] [Related]
29. Chondroblastoma-like Osteosarcoma.
Hmada YA; Bernieh A; Morris RW; Lewin J; Allen T
Arch Pathol Lab Med; 2020 Jan; 144(1):15-17. PubMed ID: 31389716
[TBL] [Abstract][Full Text] [Related]
30. Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma.
Venneker S; Szuhai K; Hogendoorn PCW; Bovée JVMG
Virchows Arch; 2020 Jan; 476(1):135-146. PubMed ID: 31728625
[TBL] [Abstract][Full Text] [Related]
31. Metastatic chondroblastoma. Report of a fatal case with a review of the literature on atypical, aggressive, and malignant chondroblastoma.
Kyriakos M; Land VJ; Penning HL; Parker SG
Cancer; 1985 Apr; 55(8):1770-89. PubMed ID: 3978565
[TBL] [Abstract][Full Text] [Related]
32. Aggressive curettage of a chondroblastoma-like osteosarcoma of the proximal end of the tibia. A case report with seven-year follow-up.
Ramos Pascua LR; Casas Ramos P; Arias Martín F; Izquierdo García FM
Skeletal Radiol; 2018 Jun; 47(6):853-857. PubMed ID: 29307095
[TBL] [Abstract][Full Text] [Related]
33. Benign cartilaginous tumors of bone: from morphology to somatic and germ-line genetics.
Romeo S; Hogendoorn PC; Dei Tos AP
Adv Anat Pathol; 2009 Sep; 16(5):307-15. PubMed ID: 19700940
[TBL] [Abstract][Full Text] [Related]
34. Periosteal chondroblastoma of the femoral neck: two cases and a review of the literature.
Guillois C; Yang S; Biau D; Feydy A; Larousserie F
Skeletal Radiol; 2024 May; 53(5):1003-1009. PubMed ID: 37733062
[TBL] [Abstract][Full Text] [Related]
35. Is Core Needle Biopsy Reliable in Differentiating Between Aggressive Benign and Malignant Radiolucent Bone Tumors?
Hegde V; Burke ZDC; Park HY; Zoller SD; Johansen D; Kelley BV; Levine B; Motamedi K; Federman NC; Seeger LL; Nelson SD; Bernthal NM
Clin Orthop Relat Res; 2018 Mar; 476(3):568-577. PubMed ID: 29529643
[TBL] [Abstract][Full Text] [Related]
36. Molecular basis for oncohistone H3 recognition by SETD2 methyltransferase.
Yang S; Zheng X; Lu C; Li GM; Allis CD; Li H
Genes Dev; 2016 Jul; 30(14):1611-6. PubMed ID: 27474439
[TBL] [Abstract][Full Text] [Related]
37. Chondroblastoma is an osteoid-forming, but not cartilage-forming neoplasm.
Aigner T; Loos S; Inwards C; Perris R; Perissinotto D; Unni KK; Kirchner T
J Pathol; 1999 Dec; 189(4):463-9. PubMed ID: 10629544
[TBL] [Abstract][Full Text] [Related]
38. Chondromyxoid fibroma-like osteosarcoma: a distinct variant of low-grade osteosarcoma.
Chow LT; Lin J; Yip KM; Kumta SM; Ahuja AT; King WW; Lee JC
Histopathology; 1996 Nov; 29(5):429-36. PubMed ID: 8951487
[TBL] [Abstract][Full Text] [Related]
39. [Giant-cell tumor of bone in 2022].
Larousserie F; Audard V; Burns R; de Pinieux G
Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
[TBL] [Abstract][Full Text] [Related]
40. Chondroblastoma-like chondroma of soft tissue: report of the first case in the base of skull.
Raparia K; Lin JW; Donovan D; Vrabec JT; Zhai QJ; Ayala AA; Ro JY
Ann Diagn Pathol; 2013 Jun; 17(3):298-301. PubMed ID: 22743240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
